How to Get Drug Shortage Alerts

How do you get notified when a drug shortage starts or ends? The FDA runs a free Drug Shortages app with alerts, plus email updates and an RSS feed, and hospital pharmacists swear by the ASHP tracker. Here is every channel, what each one actually tells you, and the gap none of them close.

The shortest path to drug shortage alerts: install the FDA's Drug Shortages app and turn on notifications. It covers current shortages, resolved shortages, and discontinuations, straight from the agency's database. That is the answer. Everything below is the longer version: what the app tells you, what it does not, and the four other channels worth knowing.

The FDA's own alert channels

The FDA runs a small constellation of notification tools, and they are better than most people expect. The Drug Shortages app, listed as "Drug Shortages 2" in the FDA's own tools directory, lets you search the shortage database and get alerts when statuses change. The database itself tracks three states for every product: current shortages, resolved shortages, and discontinuations, with the reason for the shortage, the anticipated availability date, and the manufacturer's contact information on each listing.

For email people, the FDA offers signups for updates from its Drugs site, and the MedWatch Safety Alerts feed has an RSS option for the truly committed. Anyone can also report a suspected shortage, or ask about one, at drugshortages@fda.hhs.gov or (240) 402-7770. The Drug Shortage Staff has existed since 1999, and manufacturer reporting runs through the CDER NextGen portal. The whole apparatus is manufacturer reported, which matters for the next section.

What the alerts tell you, and what they do not

An alert tells you the database changed. It does not tell you your pharmacy has the drug back. There is a real gap between "the FDA considers the shortage resolved," which happens when nationwide supply meets or exceeds projected demand, and "your corner pharmacy restocked," which depends on distributors, wholesalers, and ordering cycles. One pharmacist described it to me as the difference between the weather forecast and looking out the window. Both useful. Not the same thing.

The database also moves at manufacturer speed. Listings change when manufacturers report, and "available" on a product page reflects the manufacturer's most current information, not an FDA determination that everything is fine. Read the anticipated availability dates as estimates with wide error bars, especially early in a shortage.

The channel I would actually bookmark

Ask a hospital pharmacist where they check first and most will name the American Society of Health-System Pharmacists shortage page before the FDA's. ASHP's listings are built for clinical practice: management guidance, therapeutic alternatives, expected durations, all in one place. The FDA database is the authoritative record. ASHP is the working tool. Use both. Set the FDA app alerts for the official status changes, and keep the ASHP page bookmarked for the what-do-I-do-Monday-morning version.

A strange detail worth knowing: the FDA cannot make a company manufacture a drug, make more of it, or change who gets it. The agency says this plainly in its own materials. All the alerts in the world are a communication system draped over a market the FDA does not control. That is not a criticism. It is the reason the alerts exist instead of a fix.

The piece nobody has solved: a per-drug push notification that follows your specific prescriptions and tells you the week before your refill gets hard. The building blocks exist. Nobody has assembled them yet, at least not in a way I trust.

FAQs

One practical health-data guide a week. Get it by email.